文献速递白血病

慢性髓性白血病的预后评分系统

Prognostic scoring systems in chronic myeloid leukaemia.
PubMed 文献 · Leukemia · 2025-04-15

本文综述慢性髓性白血病(CML)预后评分系统的发展与应用,指出预后模型的重点已从单纯生存结局扩展至分子学缓解、无进展生存和CML相关生存等多样化终点,并讨论了随治疗选择演变调整预后模型的必要性及未来方向。

要点

  • CML预后模型可将患者分为预后可明确区分的组别。
  • 预后模型的重点已从单纯生存结局转向多样化终点。
  • 需随治疗演变调整模型并开展国际验证以支持个体化预后。

核心结论

  • CML预后评分系统历经发展,其关注终点已从单纯生存结局扩展至分子学缓解、无进展生存和CML相关生存等多样化终点。
  • 随着CML治疗选择演变,需调整预后模型以反映生存率以外的其他重要临床里程碑。
  • 持续完善这些工具并开展国际验证,对为临床医生提供更准确和个体化的患者预后评估至关重要。

研究设计与样本

  • 本文为综述,探讨CML预后评分系统的发展与应用,并提供使用建议及对未来进展的展望。

主要发现

  • CML预后模型已存在多年,可将患者分为预后可明确区分的组别。
  • 随着时间推移,预后模型的重点已从单纯生存结局转向更广泛多样的终点。

关键数值与推荐

  • 本文汇总的预后终点包括生存率、分子学缓解、无进展生存和CML相关生存。

临床怎么用

  • 本文为CML预后评分系统的使用提供建议,并展望该领域的潜在未来进展。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Prognostic scores are an important tool in medical statistics. In chronic myeloid leukaemia (CML), prognostic models have existed for many years, enabling the classification of patients into groups that can be clearly differentiated in terms of their prognosis. However, over time, the focus of these models has shifted from solely survival outcomes to a broader range of diverse endpoints. This review explores the development and applications of these scores, offering recommendations for their use, and looks ahead to potential future advancements in the field. As the landscape of CML treatment evolves with newer therapeutic options, it is crucial to adapt prognostic models to reflect not only survival rates but also other important clinical milestones such as molecular remission, progression-free survival, and CML-related survival. The continued refinement of these tools, alongside international validation efforts, will be essential in providing clinicians with more accurate and individualized patient prognostication, ultimately improving therapeutic decision-making and patient outcomes.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Lauseker M, Hoffmann VS, Pfirrmann M, et al. Prognostic scoring systems in chronic myeloid leukaemia. Leukemia. 2025. PMID: 40234613. doi:10.1038/s41375-025-02606-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。